Norbert Grząśko
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 31
- Multiple Myeloma Research and Treatments 31
-
- Protein Degradation and Inhibitors 16
- Glycosylation and Glycoproteins Research 2
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Co-authors
- Marek Hus (13 shared papers)Marta Morawska (11 shared papers)Anna Dmoszyńska (14 shared papers)Adam Walter‐Croneck (6 shared papers)Zhaoyang Teng (8 shared papers)Meletios Α. Dimopoulos (8 shared papers)Richard Labotka (8 shared papers)Catriona Byrne (8 shared papers)
- Journals
- Blood (9 papers)Hematological Oncology (2 papers)Pharmacological Reports (2 papers)Journal of Clinical Medicine (2 papers)European Journal Of Haematology (2 papers)
- Partner nations
- PolandUnited StatesGreece
In The Last Decade
Norbert Grząśko
39 papers receiving 484 citations
Peers
Comparison fields: 5 of 52
- Hematology 341
- Oncology 181
- Genetics 42
- Cancer Research 50
- Molecular Biology 229
Countries citing papers authored by Norbert Grząśko
This map shows the geographic impact of Norbert Grząśko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Grząśko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Grząśko more than expected).
Fields of papers citing papers by Norbert Grząśko
This network shows the impact of papers produced by Norbert Grząśko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Grząśko. The network helps show where Norbert Grząśko may publish in the future.
Co-authors
The 25 scholars most cited alongside Norbert Grząśko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 61 | |
| 2 | 2011 | 49 | |
| 3 | 2017 | 39 | |
| 4 | 2016 | 38 | |
| 5 | 2012 | 38 | |
| 6 | 2018 | 27 | |
| 7 | 2014 | 24 | |
| 8 | 2014 | 23 | |
| 9 | 2018 | 18 | |
| 10 | 2019 | 15 | |
| 11 | 2017 | 14 | |
| 12 | 2018 | 13 | |
| 13 | 2015 | 13 | |
| 14 | 2006 | 12 | |
| 15 | 2019 | 11 | |
| 16 | 2010 | 11 | |
| 17 | 2016 | 9 | |
| 18 | 2021 | 9 | |
| 19 | 2017 | 9 | |
| 20 | Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts. | 2006 | 9 |
About Norbert Grząśko
Norbert Grząśko is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 39 papers that have together received 491 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Protein Degradation and Inhibitors (16 papers), Peptidase Inhibition and Analysis (13 papers), Cancer Treatment and Pharmacology (4 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer, Lipids, and Metabolism (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (341 citations), Oncology (181 citations), Genetics (42 citations), Cancer Research (50 citations) and Molecular Biology (229 citations). Norbert Grząśko has collaborated with scholars based in Poland, United States and Greece. Frequent co-authors include Marek Hus, Marta Morawska, Anna Dmoszyńska, Adam Walter‐Croneck, Zhaoyang Teng, Meletios Α. Dimopoulos, Richard Labotka, Catriona Byrne, Andrzej Pluta and W Wiktor-Jędrzejczak. Their work appears in journals such as Blood, Hematological Oncology, Pharmacological Reports, Journal of Clinical Medicine and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.